Profil
Mr. George J.
Wasilczyk is Operating Advisor at Ennovance Capital.
He plays a critical role in Ennovance’s deal team, sourcing deals, performing due diligence and providing critical insights on market dynamics and technology assessment.
Mr. Wasilczyk is a seasoned operating executive with extensive experience in the specialty chemical industry with a unique skill set that includes P&L leadership, global marketing, R&D and technology leadership.
He was a Vice President with ICI/Henkel, (now Akzo Nobel, revenue $15B/Yr.) responsible for profitable growth.
Prior to ICI, George was General Manager at Air Products, a Fortune500 company (revenue $9B/Yr.) after starting with the company as Applications Development Manager and Technical Services and holding numerous roles of progressively increasing responsibility.
Mr. Wasilczyk earned his BS and MS in Chemistry from Rensselaer Polytechnic Institute.
He is a native Pennsylvanian.
Aktive Positionen von George J. Wasilczyk
| Unternehmen | Position | Beginn |
|---|---|---|
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above. | Berater | - |
Ausbildung von George J. Wasilczyk
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above. | Finance |
















